Gf Fund Management Co. Ltd.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
666
Total Value
4262829836
Accession Number
0002057060-25-000003
Form Type
13F-HR
Manager Name
Gf Fund Management Co. Ltd.
Data Enrichment
99% identified
658 identified8 unidentified

Holdings

666 positions
Manager:
Search and click to pin securities to the top
ALUMIS INC.
Shares:
1172(+18.1%)
Value:
$7.2M(-7.7%)
Alpha Teknova, Inc.
Shares:
1365(+22.0%)
Value:
$7.1M(-24.2%)
Vanda Pharmaceuticals Inc.
Shares:
1493(+22.0%)
Value:
$6.9M(+16.9%)
Prime Medicine, Inc.
Shares:
3358(+24.4%)
Value:
$6.7M(-15.2%)
Tectonic Therapeutic, Inc.
Shares:
377(+21.6%)
Value:
$6.7M(-53.4%)
Aquestive Therapeutics, Inc.
Shares:
2262(+18.2%)
Value:
$6.6M(-3.7%)
Personalis, Inc.
Shares:
1809(+22.0%)
Value:
$6.3M(-25.9%)
ACELYRIN, Inc.
Shares:
2569(+21.9%)
Value:
$6.3M(-4.1%)
2seventy bio, Inc.
Shares:
1280(+18.2%)
Value:
$6.3M(+98.6%)
Atea Pharmaceuticals, Inc.
Shares:
2096(+18.2%)
Value:
$6.3M(+5.5%)
CBL & ASSOCIATES PROPERTIES INC
Shares:
231(+4.0%)
Value:
$6.1M(-6.0%)
Amylyx Pharmaceuticals, Inc.
Shares:
1700(+18.1%)
Value:
$6.0M(+10.6%)
Terns Pharmaceuticals, Inc.
Shares:
2174(+21.9%)
Value:
$6.0M(-39.3%)
Coinbase Global, Inc.
Shares:
34(-24.4%)
Value:
$5.9M(-47.6%)
IRONWOOD PHARMACEUTICALS INC
Shares:
3971(+18.2%)
Value:
$5.8M(-60.8%)
Humacyte, Inc.
Shares:
3295(+22.7%)
Value:
$5.6M(-58.6%)
Design Therapeutics, Inc.
Shares:
1449(+21.9%)
Value:
$5.6M(-23.8%)
iTeos Therapeutics, Inc.
Shares:
935(+21.9%)
Value:
$5.6M(-5.2%)
CODEXIS, INC.
Shares:
2019(+18.1%)
Value:
$5.4M(-33.4%)
Olema Pharmaceuticals, Inc.
Shares:
1422(+18.2%)
Value:
$5.3M(-23.8%)